News | Cardiovascular Ultrasound | September 15, 2020

Philips Expands Cardiovascular Ultrasound With Affiniti CVx to Increase Productivity

Release 7.0 of Epiq CVx offers breakthrough interventional and productivity features to support cardiology departments managing everyday challenges

The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.

The Epiq CVxi being used for TEE imaging in the cath lab. The system brings together advanced image quality, quantification and intelligence specifically for the cardiologist.


September 15, 2020 — Philips Healthcare recently introduced the latest addition to its portfolio of dedicated cardiovascular ultrasound solutions, the Affiniti CVx. The system aims to support cardiology departments in delivering better care to more patients with increased efficiency and throughput.

With increasing patient volumes due to higher cardiac disease burden, clinicians are being asked to do more in less time and with fewer resources. The new Affiniti CVx enables a tailored workflow for cardiologists by integrating with a common platform that was first introduced with Epiq CVx, the Philips premium cardiology ultrasound system. Affiniti CVx includes a familiar configurable UI, many popular automated tools and the sharing of transducers, now including TEE transducers, across the Affiniti CVx and Epiq CVx systems. Affiniti CVx will also feature AutoStrain technology, which has been shown to reduce strain analysis time by 70%. Together, these features will enable cardiology departments to standardize their ultrasound fleet for easier management, simplify cross-platform clinician training and reduce the total cost of ownership.

At the European Society of Cardiology (ESC) 2020, Philips debuted its new Affiniti CVx and release 7.0 for Epiq CVx cardiovascular ultrasound solutions, which include improvements to enhance confidence in diagnosis and procedures, as well as improve the user experience.

“The COVID-19 pandemic has created an urgent need for nimble, user-friendly cardiac ultrasound solutions that can keep patients and healthcare providers safe while also generating the data needed to make confident decisions. With Release 7.0 of Epiq CVx and Affiniti CVx, we’ve sharpened our focus on improving the cardiology experience by increasing the integration of our platforms to meet this demand,” said Alexandra Gonçalves, M.D., MMSc, Ph.D., cardiologist and medical officer for cardiology and personal health at Philips. “Taken together, these releases help cardiology teams work faster and with greater precision and efficiency so that they can deliver the best possible heart care.”

For more information: www.philips.com/affiniti-cvx 
 

Increasing Cardiac Diagnostic Confidence With the Epiq CVx

Clinicians are needing to diagnose, plan treatments, monitor or follow up with patients more frequently. Philips Epiq CVx provides a suite of features that can significantly reduce the time spent per patient, whether in the echo lab, at the patient bedside, or during procedures.

Release 7.0 for Epiq CVx and Epiq CVxi continues Philips leadership in interventional echocardiography and will provide new ways to better appreciate morphology, to size devices, and reduce the overall procedure time. 

Industry-first dedicated tools such as 3-D Auto LAA enable faster measurements of the left atrial appendage (LAA) from 3-D increasing procedure efficiency. Cardiac TrueVue Color and Cardiac TrueVue Glass expand on the current Cardiac TrueVue photo realistic rendering by enhancing the visualization of flow, jet origin and morphology increasing clinician confidence.

Updates to the AutoStrain technology are among many additional new features to improve diagnostic confidence. AutoStrain updates will enhance confidence and efficiency in strain measurements while creating a 70% time saving in the acquisition and processing of images. These capabilities build on automated tools for strain and right heart measurements released in 2019, which have proven especially valuable in monitoring heart health in COVID-19 patients.

 
For more information: www.philips.com/esc


Related Content

Feature | Cardiac Imaging | By Mohammad Sahebjalal, MD

Invented in 1896 by Enrico Salvioni, the fluoroscope remains a flagship technology of modern medicine. The live video X ...

Home May 04, 2023
Home
News | Cardiac Imaging

April 26, 2023 — In the majority of cases, graft failure after heart transplantation is attributable to abnormalities ...

Home April 26, 2023
Home
News | Cardiac Imaging

April 14, 2023 — Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced that the U.S ...

Home April 14, 2023
Home
News | Cardiac Imaging

February 8, 2023 — Carestream Health is partnering with Robarts Research Institute to increase and demonstrate the ...

Home February 08, 2023
Home
Videos | Cardiac Imaging

Artificial intelligence and general consolidation were two top cardiology trends at RSNA22. ITN/DAIC spoke with Val ...

Home January 23, 2023
Home
News | Cardiac Imaging

January 13, 2023 — Nuclear stress testing performed with single-photon emission computed tomography (SPECT) is the most ...

Home January 13, 2023
Home
News | Cardiac Imaging

November 29, 2022 — Researchers have developed a deep learning model that uses a single chest X-ray to predict the 10 ...

Home November 29, 2022
Home
News | Cardiac Imaging

November 28, 2022 – UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power ...

Home November 28, 2022
Home
News | Cardiac Imaging

November 28, 2022 — Konica Minolta Healthcare Americas, Inc., a leader in medical diagnostic imaging and healthcare ...

Home November 28, 2022
Home
Feature | Cardiac Imaging

Discover the key features of cardiovascular structured reporting that drive adoption, including automated data flow, EHR ...

Home November 07, 2022
Home
Subscribe Now